Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer
J Clin Oncol Cannistra et al. 25:5180
Publisher’s Note
The November 20, 2007, article by Cannistra et al entitled, “Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer” (J Clin Oncol 25:5180–5186, 2007) was published online November 16, 2007 with an error. In Table 4, the number of patients with GI perforation was given as 15, whereas it should have been 5, as correctly stated in the text. This has been corrected as of March 3, 2008.
|
